New York State Common Retirement Fund’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-6,200
| Closed | -$1.37M | – | 3141 |
|
|
2025
Q4 | $1.37M | Buy |
6,200
+900
| +17% | +$145K | ﹤0.01% | 1574 |
|
|
2025
Q3 | $508K | Hold |
5,300
| – | – | ﹤0.01% | 1945 |
|
|
2025
Q2 | $258K | Buy |
+5,300
| New | +$127K | ﹤0.01% | 2149 |
|
|
2021
Q3 | – | Sell |
-14
| Closed | -$1K | – | 3364 |
|
|
2021
Q2 | $1K | Sell |
14
-1,776
| -99% | -$75.1K | ﹤0.01% | 3377 |
|
|
2021
Q1 | $95K | Sell |
1,790
-1,790
| -50% | -$88.4K | ﹤0.01% | 3085 |
|
|
2020
Q4 | $143K | Sell |
3,580
-42
| -1% | -$2.09K | ﹤0.01% | 2877 |
|
|
2020
Q3 | $206K | Hold |
3,622
| – | – | ﹤0.01% | 2628 |
|
|
2020
Q2 | $267K | Buy |
3,622
+1,530
| +73% | +$99.1K | ﹤0.01% | 2522 |
|
|
2020
Q1 | $104K | Buy |
2,092
+414
| +25% | +$24.8K | ﹤0.01% | 2758 |
|
|
2019
Q4 | $129K | Hold |
1,678
| – | – | ﹤0.01% | 2921 |
|
|
2019
Q3 | $67K | Buy |
1,678
+242
| +17% | +$8.13K | ﹤0.01% | 3115 |
|
|
2019
Q2 | $48K | Sell |
1,436
-84
| -6% | -$3.49K | ﹤0.01% | 3200 |
|
|
2019
Q1 | $81K | Sell |
1,520
-103
| -6% | -$5.65K | ﹤0.01% | 3002 |
|
|
2018
Q4 | $76K | Sell |
1,623
-72
| -4% | -$5.14K | ﹤0.01% | 3025 |
|
|
2018
Q3 | $149K | Hold |
1,695
| – | – | ﹤0.01% | 2949 |
|
|
2018
Q2 | $176K | Buy |
+1,695
| New | +$160K | ﹤0.01% | 2925 |
|
|
2017
Q2 | – | Sell |
-680
| Closed | -$106K | – | 3188 |
|
|
2017
Q1 | $106K | Hold |
680
| – | – | ﹤0.01% | 2958 |
|
|
2016
Q4 | $141K | Hold |
680
| – | – | ﹤0.01% | 2887 |
|
|
2016
Q3 | $156K | Hold |
680
| – | – | ﹤0.01% | 2850 |
|
|
2016
Q2 | $140K | Buy |
680
+460
| +209% | +$111K | ﹤0.01% | 2879 |
|
|
2016
Q1 | $56K | Hold |
220
| – | – | ﹤0.01% | 3039 |
|
|
2015
Q4 | $76K | Hold |
220
| – | – | ﹤0.01% | 3063 |
|
|
2015
Q3 | $56K | Buy |
220
+93
| +73% | +$26.6K | ﹤0.01% | 3106 |
|
|
2015
Q2 | $36K | Buy |
+127
| New | +$39.1K | ﹤0.01% | 3236 |
|
New York State Common Retirement Fund's CDTX Position: Q1 2026 in Review
New York State Common Retirement Fund sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 6,200 shares — an estimated $1.37M sold.
New York State Common Retirement Fund first reported a position in CDTX in Q2 2015 and held it in 24 quarters. The position peaked at $1.37M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.
- New York State Common Retirement Fund reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
- New York State Common Retirement Fund sold 6,200 Cidara Therapeutics shares in Q1 2026, an estimated $1.37M.
- New York State Common Retirement Fund first reported a position in Cidara Therapeutics in Q2 2015 and held it in 24 quarters.
- New York State Common Retirement Fund's Cidara Therapeutics position peaked at $1.37M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.
Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.